Peter Thompson bought $15.0M of Aspen Neuroscience stock
By AlphaYouPublished Form 4
Thompson Peter A.
Reporting filer
Peter Thompson reported buying 1,000,000 shares of Aspen Neuroscience, Inc. for about $15.0M ($15.00 a share on average). Form 4 filed Nov 4, 2026 lists 11 entries.
See the price move since this trade →
- Disclosed
- Nov 4, 2026
Reported details
11 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Thompson Peter A. | 2026-11-02 | C | Conversion | 196541 | Not stated (see footnotes) | 196,541 | 2 days | Filed terms
|
| Common Stock | Thompson Peter A. | 2026-11-02 | C | Conversion | 642745 | Not stated (see footnotes) | 839,286 | 2 days | Filed terms
|
| Common Stock | Thompson Peter A. | 2026-11-02 | C | Conversion | 616984 | Not stated (see footnotes) | 1,456,270 | 2 days | Filed terms
|
| Common Stock | Thompson Peter A. | 2026-11-02 | C | Conversion | 625743 | Not stated (see footnotes) | 2,082,013 | 2 days | Filed terms
|
| Common Stock | Thompson Peter A. | 2026-11-02 | C | Conversion | 507119 | Not stated (see footnotes) | 2,589,132 | 2 days | Filed terms
|
| Common Stock | Thompson Peter A. | 2026-11-02 | P | Purchase | 1000000 | 15.00 | 3,589,132 | 2 days | Filed terms
|
| Series Seed-2 Convertible Preferred Stock (derivative) | Thompson Peter A. | 2026-11-02 | C | Conversion | 196541 | 0 | 0 | 2 days | Filed terms
|
| Series A-1 Convertible Preferred Stock (derivative) | Thompson Peter A. | 2026-11-02 | C | Conversion | 642745 | 0 | 0 | 2 days | Filed terms
|
| Series A-2 Convertible Preferred Stock (derivative) | Thompson Peter A. | 2026-11-02 | C | Conversion | 616984 | 0 | 0 | 2 days | Filed terms
|
| Series B Convertible Preferred Stock (derivative) | Thompson Peter A. | 2026-11-02 | C | Conversion | 625743 | 0 | 0 | 2 days | Filed terms
|
| Series C Convertible Preferred Stock (derivative) | Thompson Peter A. | 2026-11-02 | C | Conversion | 507119 | 0 | 0 | 2 days | Filed terms
|
Common Stock
- Owner
- Thompson Peter A.
- Date
- 2026-11-02
- Code
- C
- Action
- Conversion
- Quantity
- 196541
- Price
- Not stated (see footnotes)
- Following holdings
- 196,541
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-02
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: C
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 196541
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 196541
- direct Or Indirect Ownership: I
- nature Of Ownership: See footnotes
- id: F3
- id: F4
Common Stock
- Owner
- Thompson Peter A.
- Date
- 2026-11-02
- Code
- C
- Action
- Conversion
- Quantity
- 642745
- Price
- Not stated (see footnotes)
- Following holdings
- 839,286
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-02
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: C
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 642745
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 839286
- direct Or Indirect Ownership: I
- nature Of Ownership: See footnotes
- id: F3
- id: F4
Common Stock
- Owner
- Thompson Peter A.
- Date
- 2026-11-02
- Code
- C
- Action
- Conversion
- Quantity
- 616984
- Price
- Not stated (see footnotes)
- Following holdings
- 1,456,270
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-02
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: C
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 616984
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 1456270
- direct Or Indirect Ownership: I
- nature Of Ownership: See footnotes
- id: F3
- id: F4
Common Stock
- Owner
- Thompson Peter A.
- Date
- 2026-11-02
- Code
- C
- Action
- Conversion
- Quantity
- 625743
- Price
- Not stated (see footnotes)
- Following holdings
- 2,082,013
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-02
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: C
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 625743
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 2082013
- direct Or Indirect Ownership: I
- nature Of Ownership: See footnotes
- id: F3
- id: F4
Common Stock
- Owner
- Thompson Peter A.
- Date
- 2026-11-02
- Code
- C
- Action
- Conversion
- Quantity
- 507119
- Price
- Not stated (see footnotes)
- Following holdings
- 2,589,132
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-02
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: C
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 507119
- id: F1
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 2589132
- direct Or Indirect Ownership: I
- nature Of Ownership: See footnotes
- id: F3
- id: F4
Common Stock
- Owner
- Thompson Peter A.
- Date
- 2026-11-02
- Code
- P
- Action
- Purchase
- Quantity
- 1000000
- Price
- 15.00
- Following holdings
- 3,589,132
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-02
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 1000000
- id: F2
- transaction Price Per Share: 15.00
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 3589132
- direct Or Indirect Ownership: I
- nature Of Ownership: See footnotes
- id: F3
- id: F4
Series Seed-2 Convertible Preferred Stock (derivative)
- Owner
- Thompson Peter A.
- Date
- 2026-11-02
- Code
- C
- Action
- Conversion
- Quantity
- 196541
- Price
- 0
- Following holdings
- 0
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Series Seed-2 Convertible Preferred Stock
- id: F1
- transaction Date: 2026-11-02
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: C
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 196541
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F1
- id: F1
- underlying Security Title: Common Stock
- underlying Security Shares: 196541
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: I
- nature Of Ownership: See footnotes
- id: F3
- id: F4
Series A-1 Convertible Preferred Stock (derivative)
- Owner
- Thompson Peter A.
- Date
- 2026-11-02
- Code
- C
- Action
- Conversion
- Quantity
- 642745
- Price
- 0
- Following holdings
- 0
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Series A-1 Convertible Preferred Stock
- id: F1
- transaction Date: 2026-11-02
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: C
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 642745
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F1
- id: F1
- underlying Security Title: Common Stock
- underlying Security Shares: 642745
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: I
- nature Of Ownership: See footnotes
- id: F3
- id: F4
Series A-2 Convertible Preferred Stock (derivative)
- Owner
- Thompson Peter A.
- Date
- 2026-11-02
- Code
- C
- Action
- Conversion
- Quantity
- 616984
- Price
- 0
- Following holdings
- 0
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Series A-2 Convertible Preferred Stock
- id: F1
- transaction Date: 2026-11-02
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: C
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 616984
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F1
- id: F1
- underlying Security Title: Common Stock
- underlying Security Shares: 616984
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: I
- nature Of Ownership: See footnotes
- id: F3
- id: F4
Series B Convertible Preferred Stock (derivative)
- Owner
- Thompson Peter A.
- Date
- 2026-11-02
- Code
- C
- Action
- Conversion
- Quantity
- 625743
- Price
- 0
- Following holdings
- 0
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Series B Convertible Preferred Stock
- id: F1
- transaction Date: 2026-11-02
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: C
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 625743
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F1
- id: F1
- underlying Security Title: Common Stock
- underlying Security Shares: 625743
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: I
- nature Of Ownership: See footnotes
- id: F3
- id: F4
Series C Convertible Preferred Stock (derivative)
- Owner
- Thompson Peter A.
- Date
- 2026-11-02
- Code
- C
- Action
- Conversion
- Quantity
- 507119
- Price
- 0
- Following holdings
- 0
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Series C Convertible Preferred Stock
- id: F1
- transaction Date: 2026-11-02
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: C
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 507119
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F1
- id: F1
- underlying Security Title: Common Stock
- underlying Security Shares: 507119
- shares Owned Following Transaction: 0
- direct Or Indirect Ownership: I
- nature Of Ownership: See footnotes
- id: F3
- id: F4
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Thompson Peter A.: Director, 10% owner.
- F1: Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, as amended, each share of Series Seed-2 Convertible Preferred Stock, Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock, and Series C Convertible Preferred Stock (collectively, the "Preferred Stock") was convertible, at the option of the holder, at any time. In connection with the completion of the Issuer's initial public offering of its Common Stock, each share of Preferred Stock automatically converted on a 1-for-9.8821 basis into shares of Common Stock, for no additional consideration. Share numbers give effect to such conversion. The securities have no expiration date.
- F2: Reflects shares of the Issuer's Common Stock purchased in the Issuer's initial public offering.
- F3: Securities held by OrbiMed Private Investments VII, LP ("OPI VII"). OrbiMed Capital GP VII LLC ("OrbiMed GP") is the general partner of OPI VII. OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of OrbiMed GP. By virtue of such relationships, OrbiMed GP and OrbiMed Advisors may be deemed to have voting and investment power with respect to the shares held by OPI VII. OrbiMed Advisors exercises investment and voting power through a management committee comprised of Carl L. Gordon, W. Carter Neild, and Geoffrey C. Hsu, each of whom disclaims beneficial ownership of the shares held by OPI VII, except to the extent of its or his pecuniary interest therein if any.
- F4: Each of the Reporting Person, OrbiMed Advisors, and OrbiMed GP disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Person, OrbiMed Advisors, or OrbiMed GP is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.
Original sources
Prepared automatically from public filing data. Report a correction.